epirubicin has been researched along with Head and Neck Neoplasms in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 9 (52.94) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davies, A; Gandara, D; Huynh, M; Johl, J; Lara, P; Lau, D; Tanaka, M | 1 |
| Chu, SC; Kao, RH; Li, CC; Wang, TF; Yao, CY | 1 |
| Hosokawa, S; Mineta, H; Morita, S; Okamura, J; Yamamoto, R; Yamatodani, T | 1 |
| Baldi, A; Citro, G; Fanciulli, M; Spugnini, EP | 1 |
| Bianco, A; Cavaniglia, G; Frattina, A; Lunghi, F; Migliorini, V; Paccagnella, A; Pappagallo, GL; Segati, R; Sileni, VC; Zorat, P | 1 |
| Clavel, M; Cognetti, F; de Mulder, PH; Kirkpatrick, A; Rodenhuis, S; Snow, GB; Vermorken, JB; Verweij, J | 1 |
| Adamo, V; Altavilla, G; Caristi, N; Chiofalo, G; Maisano, R; Pergolizzi, S; Scimone, A; Settineri, N | 1 |
| Tsukuda, M | 1 |
| Borden, EC; Green, M; Haller, DG; Marsh, JC; Rosenthal, MA; Wiernik, P | 1 |
| Baroncelli, G; La Monica, MM | 1 |
| Narasimha, K | 1 |
| Almási, L; Ambrus, E; Csernay, L; Pávics, L; Szabó, G; Tóth Bagi, Z | 1 |
| Hemmer, J | 1 |
| Caliceti, U; Guaraldi, M; Martoni, A; Occhiuzzi, L; Pannuti, F; Romagnoli, D; Rossi, AP | 1 |
| Cersosimo, RJ; Hong, WK | 1 |
| Bertetto, O; Calciati, A; Clerico, M; Dongiovanni, V | 1 |
| Bosl, GJ; Howard, J; Magee, MJ; Wittes, RE | 1 |
4 review(s) available for epirubicin and Head and Neck Neoplasms
| Article | Year |
|---|---|
Preclinical models in electrochemotherapy: the role of veterinary patients.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cat Diseases; Cats; Cisplatin; Dog Diseases; Dogs; Drug Evaluation, Preclinical; Electrochemotherapy; Epirubicin; Head and Neck Neoplasms; Melanoma; Mitoxantrone; Neoplasms; Quinazolines; Sarcoma; Thiophenes | 2012 |
[Treatment for recurrent head and neck carcinomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Combined Modality Therapy; Epirubicin; Fluorouracil; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy Dosage | 1998 |
[Effect of intra-arterial chemotherapy of head and neck tumors on cerebral blood circulation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cerebrovascular Circulation; Cisplatin; Epirubicin; Female; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon | 1992 |
Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
Topics: Bone Marrow; Breast Neoplasms; Carcinoma, Renal Cell; Carcinoma, Small Cell; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Head and Neck Neoplasms; Heart; Humans; Kidney Neoplasms; Kinetics; Leukemia; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms; Soft Tissue Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms | 1986 |
6 trial(s) available for epirubicin and Head and Neck Neoplasms
| Article | Year |
|---|---|
Population-based phase I trial of irinotecan and epirubicin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Camptothecin; Carcinoma, Non-Small-Cell Lung; Diarrhea; Drug Administration Schedule; Drug Synergism; Epirubicin; Female; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Irinotecan; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neutropenia; Topoisomerase I Inhibitors | 2008 |
A phase II study of weekly paclitaxel and epirubicin in recurrent or refractory squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug-Related Side Effects and Adverse Reactions; Epirubicin; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Platinum Compounds; Survival Analysis | 2008 |
Epirubicin, methotrexate and bleomycin in the management of recurrent squamous cell head and neck cancer. A GSTTC randomised phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Epirubicin; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis | 1993 |
Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: a phase II study of the EORTC Head and Neck Cancer Cooperative Group.
Topics: Adult; Aged; Carcinoma, Adenoid Cystic; Epirubicin; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local | 1993 |
Bleomycin, epirubicin, carboplatin (BECA) in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Epirubicin; Feasibility Studies; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Rate | 1997 |
Epirubicin has modest single-agent activity in head and neck cancer but limited activity in metastatic melanoma and colorectal cancer: phase II studies by the Eastern Cooperative Oncology Group.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Colorectal Neoplasms; Epirubicin; Female; Head and Neck Neoplasms; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1998 |
7 other study(ies) available for epirubicin and Head and Neck Neoplasms
| Article | Year |
|---|---|
[Eight cases of neuroendcrine carcinoma of the head and neck].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Epirubicin; Head and Neck Neoplasms; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy | 2008 |
Epirubicin, methotrexate and bleomycin (EMB) in the treatment of recurrent epidermoid cancer of the head and neck.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged | 1992 |
Chemotherapy of solid tumors in private practice in Malaysia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Fluorouracil; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Malaysia; Methotrexate; Mitomycin; Nasopharyngeal Neoplasms; Neoplasms; Private Practice | 1992 |
Rapid in vitro bromodeoxyuridine labeling method for monitoring of therapy response in solid human tumors.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Carcinoma; Cell Cycle; Cisplatin; Colony-Forming Units Assay; DNA, Neoplasm; Epirubicin; Flow Cytometry; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Tumor Stem Cell Assay | 1990 |
Treatment of advanced head and neck tumors with PEV-B regimen: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Evaluation; Epirubicin; Etoposide; Female; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Pilot Projects | 1988 |
Phase II trial of weekly 4-epi-doxorubicin (epirubicin) in squamous cell carcinoma of the head and neck.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Doxorubicin; Drug Evaluation; Epirubicin; Head and Neck Neoplasms; Humans | 1987 |
Phase II trial of 4'-epi-doxorubicin in advanced carcinoma of head and neck origin.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Doxorubicin; Drug Evaluation; Epirubicin; Female; Head and Neck Neoplasms; Humans; Leukocyte Count; Male; Middle Aged; Neoplasm Metastasis; Platelet Count | 1985 |